SOURCE: Graymark Healthcare, Inc.

Graymark Healthcare, Inc.

April 24, 2012 08:30 ET

Graymark Healthcare Opens Four New Facilities for Sleep Medicine Services

New Graymark Sleep Centers Opening in Atlanta and Texas

OKLAHOMA CITY, OK--(Marketwire - Apr 24, 2012) - Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), opened four new facilities for its comprehensive sleep medicine services in the second quarter of 2012.

These new sleep centers bring the aggregate number to 105 and allows Graymark to better serve patients within these markets. The locations of the new standalone Graymark sleep centers include:

  • Mesquite, TX;
  • Douglasville, GA;
  • Stockbridge, GA; and
  • Lawrenceville, GA.

Patients in the geographic regions these hospitals serve can now receive sleep medicine care in familiar surroundings, while Graymark Healthcare ensures comprehensive, state-of-the-art services. Together, the new centers will add 10 beds to the Dallas/Fort Worth and Atlanta markets.

Including today's new locations, Graymark now operates a total of 105 sleep locations nationwide, consisting of 19 standalone facilities, seven therapy facilities and 79 hospital or rural outreach locations. While the care environments may vary based on community need, Graymark ensures that the quality and comprehensiveness of the services provided remain at the highest standard.

"The opening of these four new sleep centers is directly due to the increased volume we are experiencing for our comprehensive model of diagnosing and treating patients afflicted by sleep apnea," said Stanton Nelson, CEO of Graymark Healthcare. "With the additional Atlanta locations, we were able to leverage our successful partnership with Emory-Adventist Hosipital -- our first entrance into the Georgia market -- to expand our market share in the region. The Mesquite, Texas location also represents our tenth location in the Dallas-Fort Worth region, making Graymark the market leader in terms of number of sleep studies conducted in the area."

In addition to treating all sleep disorders, including narcolepsy, insomnia, and restless leg syndrome, Graymark specializes in the treatment of sleep apnea, a sleep disorder characterized by abnormal pauses in breathing. Each pause or "apnea" can last from a few seconds to minutes, and can occur from five to more than 30 times per hour. OSA is the most common form of apnea and occurs when the soft tissue in the airway obstructs breathing. The proper diagnosis and treatment of OSA is critical due to the many significant associated health risks, including stroke and cardiac disease.

Graymark Healthcare's effective five step clinical approach to managing sleep disorders includes a convenient referral process, accurate and timely assessment, diagnosis, treatment and long-term follow-up to maximize patient compliance. All steps are managed by a board certified Sleep Medicine physician. To find out more or to locate a sleep center near you, visit

About Graymark Healthcare
Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ: GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 105 sleep laboratories primarily in the Midwest, including standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements. For more information, visit

Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements that are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the risk that the transaction does not close as planned or at all, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Company Contact:
    Graymark Healthcare, Inc.
    Stanton Nelson
    Chairman and CEO
    Tel 405-601-5300

    Investor Relations:
    Liolios Group, Inc.
    Scott Liolios or Cody Slach
    Tel 949-574-3860
    Email Contact